Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes. Abstract Text:

Christina L Aquilante,Weiming Zhang,Marianne McCollum,

OBJECTIVE: Significant race and ethnic disparities exist in diabetes-related health care. Using a nationally representative database, we sought to determine if use of thiazolidinediones (TZDs) differs by race and ethnicity. As a secondary objective, we sought to determine if race and ethnicity is associated with use of older oral antidiabetic agents, such as sulfonylureas and metformin. RESEARCH DESIGN AND METHODS: Adult respondents to the 2003 Medical Expenditure Panel Survey with diabetes, identified by diagnosis code or self-report, were included. Race/ethnic groups were defined as: White/not-Hispanic; Black/not-Hispanic; Hispanic; or Other/not-Hispanic. Associations between use of oral antidiabetic agents (defined as > or = 1 prescription for a TZD, sulfonylurea, or metformin) and race/ethnicity, sex, age, insurance status, poverty status, and having a usual source of care were evaluated in univariate analyses with chi(2) tests and in adjusted analyses using logistic regression methods for survey data. RESULTS: A total of 1873 US adults with diabetes were identified, with use of oral antidiabetic agents varying by drug class: 23.1% received TZDs, 45.3% received metformin, and 43.8% received sulfonylureas. Use of oral antidiabetic agents, by drug class, did not differ significantly by race/ethnicity (p = 0.33 for TZDs, p = 0.43 for metformin, p = 0.38 for sulfonylureas). In univariate analyses, only insurance status was significantly associated with use of TZDs (p = 0.03), and no variables were associated with use of sulfonylureas or metformin. In adjusted logistic regression analyses, there were no significant predictors of the use of TZDs or metformin, and only age was significantly associated with the use of sulfonylureas. CONCLUSIONS: In a nationally representative database, fewer US adults with diabetes received TZDs compared with sulfonylureas or metformin in 2003. Although we were not able to differentiate between type 1 and type 2 diabetes, nor did we assess oral agent monotherapy versus combination therapy, we found that use of TZDs, sulfonylureas, and metformin did not differ based on race/ethnicity or other demographic variables such as sex, insurance status, poverty status, or having a usual source of health care.

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes. Publishing Authors By Initials

CL Aquilante,W Zhang,M McCollum,

For similar geographic locations: americas: north america: united states research abstracts see: geographic locations: americas: north america: united states research

PUBMED ID PMID:

MEDLINE DATE:

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Current medical research and opinion

VOLUME: 23

Page Numbers: 489-94

Journal Abbreviation:

ISSN: 1473-4877

DAY: 3

MONTH: Mar

YEAR: 2007

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 351014

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes. Keywords Mesh Terms:

KEYWORDS: United States

MESH TERMS: economics

Chemical & Substance for Abstract: Race, ethnicity, and use of thiazolidinediones among US adults with diabetes. Information

Substance Name: Metformin

Registry Number: 657-24-9

Grant and Affiliation Information for Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.

AFFILIATION: School of Pharmacy, Department of Pharmaceutical Sciences, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA.

Country: England

AGENCY: United States NIDDK

GRANT: K23 DK073197

ACRONYM: DK

MEDLINETA: Curr Med Res Opin

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes Related Publications

• 2006-2007 national health law moot court competition: best brief.
• Argatroban therapy in patients with coronary artery disease and heparin-induced thrombocytopenia.
• Benign papilloma of the gallbladder; case report.
• Bleeding and pancreatitis.
• Bronchial carcinoma metastasising to the ischiorectal fossa.
• Can a peripheral artery be used to detect venous to arterial circulation shunts?
• Corticosteroids in retroperitoneal fibrosis.
• Head tilt-translation combinations distinguished at the level of neurons.
• INFLUENCE OF HEAT ON GROWTH-PROMOTING PROPERTIES OF FOOD.
• Is There Need for the Fortification of Milk?
• LETTERS TO THE EDITOR.
• Motion parallax contribution to perception of self-motion and depth.
• Nasomaxillary remodeling and facial form in robust Australopithecus: a reassessment.
• Paradoxical cerebral embolisation. An explanation for fat embolism syndrome.
• Present Status of Vitamin Milks.
• Prevention.
• Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
• Some legacies of nutrition pioneer E. V. McCollum.
• Spatial symmetry groups as sensorimotor guidelines.
• Stage III colon cancer at Baylor University Medical Center at Dallas and the Baylor Sammons Cancer Center: experience from 2000 to 2004.
• The Nutritional Aspects of Milk Pasteurization.
• The impact of Elmer Verner McCollum on national and global nutritional problems.
• Unchanging attitudes to autologous transfusion in the UK.
• Using Metaphors to Explore the Experiences of Powerlessness among Women in 12-Step Recovery.
• Vascular complications of prosthetic inter-vertebral discs.
• Venous leg ulcers: where does surgery fit in?
• WHAT A DENTAL SCHOOL OWES ITS ALUMNI.
• [Current knowledge on the etiology of hepatitis]